Aspergillus spp. antifungal susceptibility to triazoles and Amphotericin B

被引：0
|
作者：
Iatta, R. [1 ]
Puttilli, M. R. [1 ]
Immediato, D. [1 ]
Fracchia, L. [2 ]
Otranto, D. [1 ]
Cafarchia, C. [1 ]
机构：
[1] Univ Bari, Bari, Italy
[2] Univ Piemonte Orientale, Novara, Italy
来源：
MYCOSES | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P023
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [41] A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans
    Manavathu, EK
    Ramesh, MS
    Baskaran, I
    Ganesan, LT
    Chandrasekar, PH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) : 386 - 389
  • [42] Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea
    Won, Eun Jeong
    Shin, Jong Hee
    Kim, Soo Hyun
    Choi, Min Ji
    Byun, Seung A.
    Kim, Mi-Na
    Lee, Wee-Gyo
    Lee, Kyungwon
    Uh, Young
    Shin, Myung Geun
    Suh, Soon Pal
    MEDICAL MYCOLOGY, 2018, 56 (04) : 501 - 505
  • [43] Molecular typing and antifungal susceptibility study of Aspergillus spp. in intensive care unit (ICU) patients in Indonesia
    Rozaliyani, Anna
    Sedono, Rudyanto
    Sjam, Ridhawati
    Tugiran, Mulyati
    Adawiyah, Robiatul
    Setianingrum, Findra
    Jusuf, Anwar
    Sungkar, Saleha
    Hagen, Ferry
    Meis, Jacques F.
    Wahyuningsih, Retno
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (07): : 1014 - 1020
  • [44] Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species
    Ryder, NS
    Leitner, I
    MEDICAL MYCOLOGY, 2001, 39 (01) : 91 - 95
  • [45] Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B
    Escribano, P.
    Pelaez, T.
    Recio, S.
    Bouza, E.
    Guinea, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (02) : E24 - E26
  • [46] In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    da Silva Barros, Maria Elisabete
    Santos, Daniel de Assis
    Hamdan, Junia Soares
    MYCOLOGICAL RESEARCH, 2006, 110 : 1355 - 1360
  • [47] Susceptibility of Candida spp. clinical isolates to antifungal drugs
    Tyski, S.
    Staniszewska, M.
    Rozbicka, B.
    Rajnisz, A.
    Bocian, E.
    Wasinska, E.
    Kurzatkowski, W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S566 - S566
  • [48] Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides
    Helmerhorst, EJ
    Reijnders, IM
    van't Hof, W
    Simoons-Smit, I
    Veerman, ECI
    Amerongen, AVN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) : 702 - 704
  • [49] Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp.
    Pujol, I
    Fernández-Ballart, J
    Guarro, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (05) : 715 - 718
  • [50] Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
    Hashemi Arani, Fahimeh
    Kadow, Stephanie
    Kramer, Melanie
    Keitsch, Simone
    Kirchhoff, Lisa
    Schumacher, Fabian
    Kleuser, Burkhard
    Rath, Peter-Michael
    Gulbins, Erich
    Carpinteiro, Alexander
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
12345